Skip to main content
Emcure Pharmaceuticals Limited logo

Emcure Pharmaceuticals Limited — Investor Relations & Filings

Ticker · EMCURE ISIN · INE168P01015 LEI · 335800WYB6OIBY9EOZ42 BSE.NS Manufacturing
Open in API
Filings indexed 201 across all filing types
Latest filing 2026-05-27 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS EMCURE

About Emcure Pharmaceuticals Limited

https://www.emcure.com

Emcure Pharmaceuticals Limited is a research-driven global pharmaceutical organization engaged in the development, manufacturing, and marketing of a broad range of differentiated pharmaceutical products. The company maintains a diverse portfolio across several key therapeutic areas, including gynaecology, cardiovascular, oncology, anti-infectives, and HIV/AIDS. With a strong emphasis on research and development, Emcure operates multiple state-of-the-art manufacturing facilities and R&D centers globally. Its business model focuses on complex generics and innovative formulations, serving healthcare needs in over 70 countries. The company is recognized for its vertically integrated operations and commitment to high-quality standards, catering to both regulated and emerging markets worldwide.

Recent filings

Filing Released Lang Actions
Allotment of Securities
Share Issue/Capital Change Classification · 94% confidence The document is a stock exchange filing under SEBI Regulation 30 announcing the allotment of 70,000 equity shares upon exercise of employee stock options, resulting in an increase in the issued and paid-up share capital. This is a share issue/capital change disclosure rather than a full report, financing announcement, or management change. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-05-27 English
Allotment of Equity Shares pursuant to exercise of ESOPs under the Emcure - Emcure Stock Option Scheme 2013.
Share Issue/Capital Change Classification · 95% confidence The document is an exchange filing under SEBI Listing Regulations announcing the allotment of 70,000 equity shares upon exercise of employee stock options, resulting in an increase in the company’s issued and paid-up share capital. This constitutes a share issue/capital change rather than a full financial report or other category. It matches the definition of Share Issue/Capital Change (Code: SHA).
2026-05-27 English
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
Regulatory Filings Classification · 95% confidence The document is a secretarial compliance certificate prepared by a practicing company secretary under Regulation 24A of SEBI LODR. It is a regulatory filing/certificate attesting compliance with SEBI regulations, not the company’s financial statements or an operational report. According to the CERTIFICATION RULE and the fallback for miscellaneous compliance filings, this should be classified as a Regulatory Filing (RNS).
2026-05-27 English
Intimation of schedule of Analyst/ Investor Meeting on June 09, 2026
Regulatory Filings Classification · 85% confidence The document is an SEBI (Listing Obligations and Disclosure Requirements) Regulation 30 intimation to stock exchanges disclosing the schedule of analyst/investor meetings. It does not contain financial results, presentations, or actual report content, nor does it announce voting results, capital changes, or dividends. This is a routine regulatory disclosure under listing rules, making it a general regulatory filing.
2026-05-20 English
Intimation of schedule of Analyst/ Investor Meeting on June 01, 2026
Regulatory Filings Classification · 81% confidence The document is an exchange intimation under SEBI LODR Regulation 30, notifying the schedule of analyst/investor meetings. It does not present financial results, reports, or detailed investor presentations, nor does it amend capital structure or governance. It is a regulatory announcement, fitting the fallback category for miscellaneous filings (Regulatory Filings).
2026-05-20 English
Intimation of schedule of Analyst/ Investor Meeting on May 27, 2026
Regulatory Filings Classification · 88% confidence The document is a SEBI LODR regulatory filing notifying exchanges of the schedule for analyst/investor meetings. It does not contain financial statements, a presentation deck, or declare dividends, nor is it an AGM notice or earnings release. It is a general regulatory announcement under Listing Obligations and Disclosure Requirements, fitting the fallback category Regulatory Filings (RNS).
2026-05-20 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.